SCHEMBL1136739

SCHEMBL1136739

NC/C=C\CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL918780 1.00
SCHEMBL918782 1.00
Hydrochloric Acid SCHEMBL8950368 0.94
Hydrochloric Acid SCHEMBL587862 0.94
Hydrochloric Acid SCHEMBL587863 0.94
SCHEMBL11087531 0.85 GABRR1 (0.35)
SCHEMBL10884253 0.85 GABRR1 (0.35)
SCHEMBL10603077 0.85
SCHEMBL249964 0.78
SCHEMBL1998723 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130211168-A1 CATALYTIC COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF OLEFINS USING SAID CATALYTIC COMPOSITION IFP Energies Nouvelles (FR) 2013-08-15 US claimed
US-6485665-B1 SEGMENTED POLYURETHANE POLYMER PRODUCED ON THE BASIS OF A MACRO-DIOL, AN ALIPHATIC DIISOCYANATE, AND A CHAIN EXTENDER IS MELT-EXTRUDED TO FORM A FIBER AND CURED RHODIANYL S.N.C. (FR) 2002-11-26 US claimed
US-20230303776-A1 FULLY AND PARTIALLY BACKBONE-DEGRADABLE POLYMERS VIA LOW TEMPERATURE RING-OPENING METATHESIS POLYMERIZATION (ROMP) NORTHWESTERN UNIVERSITY (US) 2023-09-28 US disclosed
CN-113444023-B Synthesis method and application of tert-butoxycarbonyl protected ammonia compound 成都先导药物开发股份有限公司 2023-05-02 CN disclosed
WO-2022006387-A9 FULLY AND PARTIALLY BACKBONE-DEGRADABLE POLYMERS VIA LOW TEMPERATURE RING-OPENING METATHESIS POLYMERIZATION (ROMP) NORTHWESTERN UNIVERSITY (US) 2022-04-14 WO disclosed
EP-3831372-A1 MITOGUAZONE FOR PREVENTING THE RELAPSE OR THE PROGRESSION OF MULTIPLE SCLEROSIS Pathologica LLC (US) 2021-06-09 EP disclosed
EP-2416780-B1 COMBINATION OF DECITABINE WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER OTSUKA PHARMA CO LTD (JP) 2017-03-08 EP disclosed
EP-2416781-B1 COMBINATION OF CYTIDINE-BASED ANTINEOPLASTIC DRUGS WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER OTSUKA PHARMA CO LTD (JP) 2017-03-08 EP disclosed
EP-2417146-B1 (2'-DEOXY-RIBOFURANOSYL)-1,3,4,7-TETRAHYDRO-(1,3)DIAZEPIN-2-ONE DERIVATIVES FOR TREATING CANCER OTSUKA PHARMA CO LTD (JP) 2016-07-13 EP disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
WO-2016009195-A1 ENZYMATIC PROCESSES AND USES THE UNIVERSITY OF MANCHESTER (GB) 2016-01-21 WO disclosed
WO-2007106554-A2 TREATMENT AND PREVENTION OF VASCULAR HYPERPLASIA USING POLYAMINE AND POLYAMINE ANALOG COMPOUNDS PROGEN PHARMACEUTICALS, INC. (US) 2007-09-20 WO disclosed
WO-2006084369-A1 DIAMINE CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD. (CA) 2006-08-17 WO disclosed
EP-1248764-A2 NOVEL METHODS FOR CROSS-METATHESIS OF TERMINAL OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2002-10-16 EP disclosed
US-6414097-B1 CONTACTING FIRST TERMINAL OLEFIN WITH SECOND DISUBSTITUTED OLEFIN IN PRESENCE OF RUTHENIUM OR OSMIUM CONTAINING CATALYST CALIFORNIA INSTITUTE OF TECHNOLOGY 2002-07-02 US disclosed
US-6306988-B1 DIMERIZATION OF OLEFINS IN THE PRESENCE OF RUTHENIUM OR OSMIUM COMPOUND CALIFORNIA INSTITUTE OF TECHNOLOGY 2001-10-23 US disclosed
WO-2000043343-A2 NOVEL METHODS FOR CROSS-METATHESIS OF TERMINAL OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-07-27 WO disclosed
WO-1992008707-A1 CHELATING AGENTS COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) 1992-05-29 WO disclosed
WO-1981002164-A1 SEVEN-MEMBERED RING COMPOUNDS AS INHIBITORS OF CYTIDINE DEAMINASE US COMMERCE (US) 1981-08-06 WO disclosed
US-4275057-A CANCER AND ANTITUMOR DRUG RESEARCH THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1981-06-23 US disclosed